Brent Hatzis-Schoch
2022 - Black Diamond Therapeutics
In 2022, Brent Hatzis-Schoch earned a total compensation of $911.2K as Chief Operating Officer, General Counsel at Black Diamond Therapeutics, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,743 |
|---|---|
| Option Awards | $227,932 |
| Salary | $452,100 |
| Other | $23,452 |
| Total | $911,227 |
Hatzis-Schoch received $452.1K in salary, accounting for 50% of the total pay in 2022.
Hatzis-Schoch also received $207.7K in non-equity incentive plan, $227.9K in option awards and $23.5K in other compensation.
Rankings
In 2022, Brent Hatzis-Schoch's compensation ranked 3,189th out of 5,538 executives tracked by ExecPay. In other words, Hatzis-Schoch earned more than 42.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,189 out of 5,538 | 42nd |
Division Manufacturing | 1,782 out of 3,000 | 41st |
Major group Chemicals And Allied Products | 841 out of 1,350 | 38th |
Industry group Drugs | 785 out of 1,253 | 37th |
Industry Biological Products, Except Diagnostic Substances | 193 out of 287 | 33rd |
Source: SEC filing on April 4, 2023.
Hatzis-Schoch's colleagues
We found two more compensation records of executives who worked with Brent Hatzis-Schoch at Black Diamond Therapeutics in 2022.
News
Black Diamond Therapeutics CEO David Epstein's 2022 pay falls 68% to $1.6M
April 4, 2023
Black Diamond Therapeutics CEO David Epstein's 2021 pay jumps 32% to $5.1M
April 28, 2022
Radius Health CEO Jesper Hoeiland's 2019 pay falls 28% to $3.9M
April 17, 2020
Radius Health CEO Jesper Høiland's 2018 pay falls 29% to $5.4M
April 18, 2019